Apple's long-anticipated entry into the foldable smartphone market has run into trouble before the product ever reached a store shelf. The company has...
Hardly for the first time in recent days, it announced an expansion of an important credit facility.
Whatever happens with the war, long-term investors shouldn't panic.
This is the latest move by the hedge fund manager to be the modern-day Warren Buffett.
On April 7, 2026, investors weighed a bold AI chip alliance and broader strategic moves reshaping this chipmaker’s trajectory.
Nvidia's stock has struggled this year.
On March 31, 2026, NVIDIA Corporation and Marvell Technology announced that NVIDIA would invest US$2.00 billion via convertible preferred stock and en...
Intel is coming on board Elon Musk's ambitious Terafab chip-production project.
Investors weren't cheered by news of a secondary unit sale.
Production may be delayed as issues persist
In the closing of the recent trading day, Verizon Communications (VZ) stood at $48.62, denoting a -1.08% move from the preceding trading day.
The artificial intelligence platform specialist has been growing revenues at a torrid pace since the AI megatrend shifted into high gear.
The stock market closed narrowly mixed after whipsaw action ahead of Trump's Iran War deadline at 8 p.m. ET.
Markets are rejoicing after President Donald Trump announced a two week cease-fire with Iran and Tehran signaled a reopening of the Strait of Hormuz.
Health insurers gained today on Medicare Advantage payment rate news while investors watch developments in the Iran conflict, today, April 7, 2026.
Nvidia stock was down for much of Tuesday but ended the trading session up slightly amid concerns that the Iran war was set to escalate. It’s still ...
Investors juggle foldable iPhone setbacks, softer services growth, and fresh Wall Street optimism on this tech leader, today, April 7, 2026.
Catch up on the stories we’re following today
Following Google's release of TurboQuant, shares of Micron Technology have lost their momentum.
It's getting a cash infusion from its giant pharmaceutical partner.
Loading...